Menu
GeneBe

RNF34

ring finger protein 34, the group of Ring finger proteins

Basic information

Region (hg38): 12:121400082-121430623

Links

ENSG00000170633NCBI:80196OMIM:608299HGNC:17297Uniprot:Q969K3AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the RNF34 gene.

  • Inborn genetic diseases (10 variants)
  • not provided (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNF34 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
8
clinvar
2
clinvar
1
clinvar
11
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 8 2 1

Variants in RNF34

This is a list of pathogenic ClinVar variants found in the RNF34 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
12-121416174-A-G not specified Uncertain significance (Feb 21, 2024)3155409
12-121416312-G-A not specified Uncertain significance (Jan 29, 2024)3155408
12-121416336-T-G not specified Uncertain significance (Jun 06, 2023)2515801
12-121417567-C-T not specified Uncertain significance (Sep 06, 2022)2310229
12-121417690-C-T not specified Uncertain significance (Nov 18, 2022)2387622
12-121417707-G-T not specified Uncertain significance (Jul 11, 2023)2610423
12-121417724-G-A not specified Uncertain significance (Dec 16, 2021)2267604
12-121417808-G-A Benign (Jun 02, 2018)778448
12-121417811-C-T not specified Uncertain significance (Sep 21, 2023)3155411
12-121417894-T-C not specified Uncertain significance (May 27, 2022)2209947
12-121420295-T-G not specified Uncertain significance (Sep 26, 2023)3155412
12-121420301-T-G not specified Likely benign (Feb 09, 2022)2264515
12-121420313-A-T not specified Likely benign (Aug 12, 2021)2377433
12-121420679-G-T not specified Uncertain significance (Jan 26, 2023)3155413
12-121420683-G-A not specified Uncertain significance (Jul 05, 2023)2595100
12-121420743-G-A not specified Uncertain significance (Jan 20, 2023)2476983
12-121423391-G-A not specified Uncertain significance (Mar 01, 2024)3155414
12-121430113-G-A KDM2B-related disorder Likely benign (Apr 11, 2019)3058765
12-121430121-C-T KDM2B-related disorder Uncertain significance (Jan 31, 2023)2630233
12-121430125-C-T KDM2B-related disorder Likely benign (Feb 04, 2020)3043603
12-121430138-G-A KDM2B-related disorder Uncertain significance (Feb 05, 2024)3045774
12-121430362-G-A Uncertain significance (Aug 25, 2022)2430752
12-121430436-A-G Uncertain significance (Dec 08, 2023)2885855

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
RNF34protein_codingprotein_codingENST00000392465 630546
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6110.3891257320161257480.0000636
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.441592190.7260.00001332434
Missense in Polyphen60103.80.578021089
Synonymous0.7517886.90.8970.00000570719
Loss of Function3.01316.00.1887.61e-7209

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002100.000210
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.00004620.0000462
European (Non-Finnish)0.00006170.0000615
Middle Eastern0.00005440.0000544
South Asian0.00006820.0000653
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: E3 ubiquitin-protein ligase that regulates several biological processes through the ubiquitin-mediated proteasomal degradation of various target proteins. Ubiquitinates the caspases CASP8 and CASP10, promoting their proteasomal degradation, to negatively regulate cell death downstream of death domain receptors in the extrinsic pathway of apoptosis (PubMed:15069192). May mediate 'Lys-48'-linked polyubiquitination of RIPK1 and its subsequent proteasomal degradation thereby indirectly regulating the tumor necrosis factor-mediated signaling pathway (Ref.13). Negatively regulates p53/TP53 through its direct ubiquitination and targeting to proteasomal degradation (PubMed:17121812). Indirectly, may also negatively regulate p53/TP53 through ubiquitination and degradation of SFN (PubMed:18382127). Mediates PPARGC1A proteasomal degradation probably through ubiquitination thereby indirectly regulating the metabolism of brown fat cells (PubMed:22064484). Possibly involved in innate immunity, through 'Lys-48'-linked polyubiquitination of NOD1 and its subsequent proteasomal degradation (PubMed:25012219). {ECO:0000269|PubMed:12118383, ECO:0000269|PubMed:15069192, ECO:0000269|PubMed:15897238, ECO:0000269|PubMed:17121812, ECO:0000269|PubMed:22064484, ECO:0000269|PubMed:25012219, ECO:0000269|Ref.13, ECO:0000303|PubMed:18382127}.;
Pathway
Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Regulation of TP53 Degradation;Regulation of TP53 Expression and Degradation;Regulation of TP53 Activity;Transcriptional Regulation by TP53 (Consensus)

Recessive Scores

pRec
0.160

Intolerance Scores

loftool
0.642
rvis_EVS
-0.34
rvis_percentile_EVS
30.37

Haploinsufficiency Scores

pHI
0.316
hipred
N
hipred_score
0.477
ghis
0.526

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.627

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Rnf34
Phenotype

Gene ontology

Biological process
ubiquitin-dependent protein catabolic process;apoptotic process;protein ubiquitination;nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway;proteasome-mediated ubiquitin-dependent protein catabolic process;cellular response to cold;protein K48-linked ubiquitination;negative regulation of signal transduction by p53 class mediator;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;regulation of oxygen metabolic process;negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis
Cellular component
nucleus;nucleoplasm;cytoplasm;cytosol;plasma membrane;endomembrane system;nuclear body;nuclear speck
Molecular function
p53 binding;protein binding;ubiquitin protein ligase binding;metal ion binding;ubiquitin protein ligase activity;phosphatidylinositol phosphate binding